Review | SARS-COV-2 Neutralizing Antibodies

Team Annar
Content creation
SHARE

Review SARS-COV-2 Neutralizing Antibodies

Casa Comercial Asociada: DIA.PRO


Neutralizing antibodies to SARS COV 2 are antibodies capable of stopping the binding of host cell receptors to the virus receptor located on the spicule.

They are relevant because they are the antigenic target for vaccine development, and are responsible for host protection against infection.

Currently there are in vitro diagnostic products that allow the quantification of these IgG isotype antibodies that, when used with responsibility and knowledge, will provide valuable information to improve the management of vaccines and the knowledge of this viral infection.

 

 


 

Most viewed

invitro-news-revista-salud-annard

At ANNAR we are agents of change!

Significance of ART vs. CD4 ratio

Multiple myeloma in Colombia, its impact and the need for timely diagnosis.

invitro-news-revista-gestion-salud-oximetros

Syndromic Dx: Efficient outcomes for proper patient management